Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clinigen Group PLC

www.clinigengroup.com

Latest From Clinigen Group PLC

Asia Deal Watch: Antibody-Drug Conjugates Reign With Alliances Involving Celltrion, Miracogen & WuXi Biologics

Celltrion and iProgen will co-develop ADC candidates, Miracogen and Synaffix sign a technology license after a successful research collaboration, and WuXi will provide clinical trial material to NBE Therapeutics.

Deals Commercial

Novartis, Zurich University Spin-out Anaveon Tackles IL-2 Challenges With Fresh Funds

Syncona and Novartis Venture Fund have invested CHF35m in Anaveon, which reckons it can overcome the toxicity and half-life limitations of the cytokine interleukin-2 to enhance the body’s immune response to tumors.

Financing ImmunoOncology

Deal Watch: Roivant Spins Out Arvelle, Licenses Epilepsy Candidate From SK Biopharma

Already having launched several portfolio companies, Roivant goes a step further by spinning out CNS specialist Arvelle from Axovant. BI and IBM will incorporate blockchain technology in clinical trials, while AbbVie licenses multiple myeloma candidate from TeneoBio.

Business Strategies Commercial

US Rights Deal Will Make Proleukin Clinigen's Biggest Product

Clinigen's planned purchase of US rights to Proleukin will give it global ownership of the IL-2 drug.

Business Strategies Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Clinigen Group PLC
  • Senior Management
  • Shaun Chlton, CEO
    Martin Abell, CFO
    Simon Estcourt, COO
    Paul Thomas, CTO
  • Contact Info
  • Clinigen Group PLC
    Phone: 1283 494 340
    Pitcairn House, Crown Sq., First Ave.
    Centrum 100
    Burton-on-Trent, DE14 2WW
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register